Sagentia Selected As Development Partner For Set Point Medicall’s Novel Neuromodulation Device To Treat Chronic Inflammatory Diseases
BOSTON--(BUSINESS WIRE)--Sagentia, a global technology and product development company, has been hired by SetPoint Medical to work on the development of the programming interface for a neuromodulation device. The device aims to provide patients with a lower risk and lower cost alternative to immunosuppressive drugs for the treatment of chronic inflammatory diseases.
Help employers find you! Check out all the jobs and post your resume.